|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/00 | |
| A61K 31/497 | |||
| A61K 31/4162 | |||
| C12Q 1/6886 | |||
| G01N 33/574 | |||
| A61P 35/00 | |||
| A61K 31/52 |
| (11) | Number of the document | 2825161 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13711265.2 |
| Date of filing the European patent application | 2013-03-12 | |
| (97) | Date of publication of the European application | 2015-01-21 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/030565 |
| Date | 2013-03-12 |
| (87) | Number | WO 2013/138361 |
| Date | 2013-09-19 |
| (30) | Number | Date | Country code |
| 201213418242 | 2012-03-12 | US |
| (72) |
KUNTZ, Kevin, Wayne, US
KNUTSON, Sarah, Kathleen, US
WIGLE, Timothy James, Nelson, US
|
| (73) |
Epizyme, Inc.,
400 Technology Square, 4th Floor, Cambridge, MA 02139,
US
|
| (54) | INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF |
| INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF |